# Protara Therapeutics, Inc. (TARA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/TARA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -17.78M | $ -21.34M | $ 3.06M | $ 181.21M |
| 2025 | $ 0 | $ -58.81M | $ -57.81M | $ 3.36M | $ 196.41M |
| 2024 | $ 0 | $ -46.87M | $ -37.70M | $ 4.48M | $ 167.13M |
| 2023 | $ 0 | $ -43.70M | $ -40.66M | $ 5.47M | $ 68.32M |
| 2022 | $ 0 | $ -73.68M | $ -29.69M | $ 6.38M | $ 102.08M |
| 2021 | $ 0 | $ -56.17M | $ -41.72M | $ 7.24M | $ 161.91M |
| 2020 | $ 0 | $ -43.29M | $ -30.95M | $ 1.09M | $ 199.24M |
| 2019 | $ 0 | $ -3.52M | $ -7.08M | $ 0 | $ 6.39M |
| 2018 | $ 0 | $ -22.29M | $ -26.31M | $ 0 | $ 20.44M |
| 2017 | $ 0 | $ -40.37M | $ -30.16M | $ 0 | $ 34.74M |
| 2016 | $ 0 | $ -39.25M | $ -32.97M | $ 0 | $ 38.44M |
| 2015 | $ 0 | $ -30.00M | $ -24.95M | $ 0 | $ 63.41M |
| 2014 | $ 4.17M | $ -322.2K | $ -2.91M | $ 0 | $ 82.46M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.02 |
| Liabilities / Eq | 0.06 |
| Current Ratio | 15.69 |

## Other views

- [Metrics](https://sponda.capital/en/TARA.md)
- [Charts](https://sponda.capital/en/TARA/charts.md)
- [Compare](https://sponda.capital/en/TARA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.